Loading clinical trials...

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Symptom Reporting by Children, Adolescents and Young Adults With Cancer and Their Caregivers During a Clinic Visit: A Feasibility, Usability and Acceptability Study

NCT06824441•Stanford University

View on ClinicalTrials.gov

Summary

The purpose of this project is to pilot test an electronically delivered symptom assessment tool Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (Ped-PRO-CTCAE), completed by children/adolescents and young adults (AYAs) and caregivers and shared with their clinicians during an outpatient clinic visit, in preparation for a future test of intervention efficacy.

Eligibility

Age

7 - 21 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. First diagnosis of cancer
•2. Receiving cancer therapy: surgery, myelosuppressive chemotherapy and/or radiation 7-21 years of age
•3. Completed at least 1 month of cancer chemotherapy treatment and are within 7-28 days of starting a treatment cycle or during ongoing therapy, followed at least every month in clinic
•4. If surgery was part of treatment, the patient must be 3-6 weeks post surgery before participating in study
•5. Caregiver must be present and 18 years and older
•6. Ability to understand and the willingness to personally sign the written IRB-approved informed consent or assent document as appropriate
•7. Disease can be newly diagnosed, in relapse or refractory, as long as this is the first diagnosis of cancer
•8. Child must be able to read or listen to and understand English

Exclusion Criteria

•1\. Child must not have cognitive/memory impairments determined by the child's clinician

Locations (1)

Stanford University

Palo Alto, California, United States

Key Dates

Start Date

August 18, 2024

Primary Completion Date

October 1, 2026

Completion Date

October 1, 2026

Last Updated

March 12, 2026

Enrollment

ACTUAL participants

Conditions

Adolescent BehaviorPediatric CancerOncology

Interventions

Age- and Role-Specific Questionnaire Administration

BEHAVIORAL

Rigorous Evaluation of Let's Talk Birth Control

NCT06670066

Sexual BehaviorAdolescent Behavior

View study

RECRUITINGNA

Sustaining Physical Activity After Cancer Exercise Sessions

NCT06359210

Exercise OncologyPhysical Activity Behavior+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 12, 2026Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer

Inclusion Criteria

Exclusion Criteria

Rigorous Evaluation of Let's Talk Birth Control

Sustaining Physical Activity After Cancer Exercise Sessions

Insights on Dissemination of Lung Cancer

Leading Healthy Eating and Activity Promotion Program

Lurbinectedin in FET-Fused Tumors

Multicentre Randomised Study Comparing a Taurolidine Lock and a Standard Saline Lock in Paediatric Oncology